Ucommune International Ltd. UK
2.10
0.00
0.00%
as of 25 Sep
- Market cap
- $1.4M
- P/E
- 0.0×
Follow UK
| Older periods | Dec '22 | Jun '23 | Jun '24 | Jun '25 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(196.59%) | (196.14%) | 0.00% | 0.00% | |
| (85.41%) | (88.52%) | 0.00% | 0.00% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(6,781.45%) | 1,129.41% | 0.00% | 0.00% | |
Average Days of Receivables |
64.80 | 36.57 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(69.05) | (100.32) | 0.00 | — | |
Free Cash Flow |
(29.49) | (44.53) | (41.69) | — | |
Capital Expenditures |
— | (19.53) | (19.74) | — | |
Piotroski F-Score |
1.00 | 1.00 | — | — | |
| Other line items | |||||
Cash ROIC |
(41.28%) | (79.33%) | (140.66%) | 0.00% | |
Accounts Receivable Turnover |
6.86 | 9.14 | 0.00 | 0.00 | |
Accounts Payable Turnover |
5.33 | 5.88 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | — | — | |
Average Days of Payables |
73.18 | 59.90 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | — | — | |
Tax Rate |
0.00 | 0.00 | — | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | — | — | |
Selling, General and Administrative Expense of Revenue |
26.41% | 21.70% | — | — | |
Share Based Compensation of Revenue |
0.00% | 0.00% | — | — | |
Operating CF/Net income |
0.10 | 0.09 | 0.00 | — | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
— | 0.00 | 0.00 | — | |
Revenue per Share |
430.78 | 409.76 | — | — | |
Operating CF per Share |
(69.05) | (56.33) | 0.00 | — | |
Capex per Share |
0.00 | (43.99) | 0.00 | — | |
Capex to Sales |
0.00 | 0.11 | 0.00 | — | |
Net Profit Margin |
(168.11%) | (158.43%) | — | — |
Columns are period end dates